Format

Send to

Choose Destination
Nat Rev Drug Discov. 2011 Sep 30;10(10):729-30. doi: 10.1038/nrd3561.

Ezogabine (retigabine).

Author information

1
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53705, USA. stafstrom@neurology.wisc.edu

Abstract

Ezogabine (Potiga; Valeant Pharmaceuticals/GlaxoSmithKline), a potassium channel opener, was approved in June 2011 by the U.S. Food and Drug Administration (F.D.A.) for the adjunctive treatment of partial-onset seizures in adult patients. The same drug was granted marketing authorization for this indication in the European Union in March 2011, where it is known as retigabine (Trobalt).

PMID:
21959281
DOI:
10.1038/nrd3561
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center